Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 3/20 | 0.50 |
| ▸ | HTR6 | P50406 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | MMP14 | P50281 | 1/20 | 0.45 |
| ▸ | MMP16 | P51512 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL502864 | 1.00 | CASP1 (0.50) | CASP1HTR6GAALMNAKMT2A | |
| Ammonia Solution, Strong SCHEMBL502557 | 0.98 | CASP1 (0.49) | CASP1HTR6GAALMNAKMT2A | |
| SCHEMBL11599660 | 0.98 | CASP1 (0.49) | CASP1HTR6GAALMNAKMT2A | |
| SCHEMBL9323437 | 0.90 | HTR6 (0.65) | CASP1HTR6GAALMNAKMT2A | |
| SCHEMBL11600047 | 0.89 | CASP1 (0.43) | CASP1HTR6GAALMNAKMT2A | |
| SCHEMBL11186053 | 0.87 | MMP13 (0.61) | CASP1HTR6LMNAPTGS2MMP2 | |
| Biphenyl SCHEMBL1071653 | 0.85 | HTR6 (0.59) | CASP1HTR6KMT2APTGS2MMP2 | |
| SCHEMBL28656015 | 0.85 | PTGS2 (0.54) | CASP1HTR6GAALMNAKMT2A | |
| SCHEMBL10411384 | 0.84 | LMNA (0.43) | CASP1HTR6GAALMNAKMT2A | |
| SCHEMBL30340391 | 0.84 | NCOA1 (0.51) | CASP1HTR6GAAKMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0866110-B1 | Light-emitting material for organo-electroluminescence device and organic electroluminescence device | TOYO INK MFG CO (JP) | 2004-10-20 | — | — | EP | claimed |
| US-5374469-A | Using thermoplastic polyimide resin showing adhesive properties by press bending by heating, using low-linear expansion polyimide | NITTO DENKO CORPORATION (JP) | 1994-12-20 | — | — | US | claimed |
| EP-0533198-A2 | Flexible printed substrate | NITTO DENKO CORPORATION (JP) | 1993-03-24 | — | — | EP | claimed |
| US-4584364-A | Phenolic-capped imide sulfone resins | THE BOEING COMPANY (US) | 1986-04-22 | — | — | US | claimed |
| US-4499258-A | HEAT-RESISTANT LAMINATES; FILMS;HIGH STRENGTH | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1985-02-12 | — | — | US | claimed |
| US-4414380-A | IN POLYCARBONYLS | UOP INC. (US) | 1983-11-08 | — | — | US | claimed |
| US-20230255943-A1 | MMP-9 AND MMP-12 INHIBITION FOR TREATING SPINAL CORD INJURY OR RELATED INJURY TO NEUROLOGICAL TISSUE | THE UNIVERSITY OF BIRMINGHAM (GB) | 2023-08-17 | — | — | US | disclosed |
| EP-4171553-A1 | MMP-9 AND MMP-12 INHIBITION FOR TREATING SPINAL CORD INJURY OR RELATED INJURY TO NEUROLOGICAL TISSUE | The University Of Birmingham (GB) | 2023-05-03 | — | — | EP | disclosed |
| CN-116033902-A | Methods of treating spinal cord injury or related nerve tissue injury | 伯明翰大学 | 2023-04-28 | — | — | CN | disclosed |
| WO-2021260387-A1 | MMP-9 AND MMP-12 INHIBITION FOR TREATING SPINAL CORD INJURY OR RELATED INJURY TO NEUROLOGICAL TISSUE | THE UNIVERSITY OF BIRMINGHAM (GB) | 2021-12-30 | — | — | WO | disclosed |
| EP-2438106-B1 | OLIGOMERS WITH DI-PHENYLETHYNYL ENDCAPS | BOEING CO (US) | 2015-03-11 | — | — | EP | disclosed |
| CN-102307933-B | Oligomers with diphenylethynyl endcaps | BOEING CO | 2014-05-07 | — | — | CN | disclosed |
| EP-2438106-A1 | OLIGOMERS WITH DI-PHENYLETHYNYL ENDCAPS | The Boeing Company (US) | 2012-04-11 | — | — | EP | disclosed |
| EP-0305882-A2 | Amideimide oligomers & blends | THE BOEING COMPANY (US) | 1989-03-08 | — | — | EP | disclosed |
| US-4764566-A | HIGH STRENGTH | ALLIED-SIGNAL INC. (US) | 1988-08-16 | — | — | US | disclosed |
| US-4684714-A | Method for making polyimide oligomers | THE BOEING COMPANY (US) | 1987-08-04 | — | — | US | disclosed |
| US-4414380-A | IN POLYCARBONYLS | UOP INC. (US) | 1983-11-08 | — | — | US | disclosed |
| US-4414380-A | IN POLYCARBONYLS | UOP INC. (US) | 1983-11-08 | — | — | US | disclosed |
| US-4203922-A | Fluorinated aromatic diamine | TRW INC. (US) | 1980-05-20 | — | — | US | disclosed |
| US-4111906-A | POLYIMIDES PREPARED FROM PERFLUOROISOPROPYLIDENE DIAMINE | TRW INC. (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255943-A1 | MMP-9 AND MMP-12 INHIBITION FOR TREATING SPINAL CORD INJURY OR RELATED INJURY TO NEUROLOGICAL TISSUE | MMP12, MMP13, MMP10 | CASP1 209/4885HTR6 2917/4885GAA 635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.